The widespread adoption of diets that significantly reduce carbohydrate intake, often lauded for potential benefits in weight management and glycemic control, presents a complex physiological landscape with respect to lipid profiles, particularly low-density lipoprotein (LDL) cholesterol. While many individuals report neutral or even favorable changes in their cholesterol levels on such regimens, a notable subset experiences a concerning elevation in LDL, a well-established risk factor for cardiovascular disease. Emerging research is illuminating a crucial factor behind this disparity: an individual’s genetic blueprint appears to play a pivotal role in modulating how the body metabolizes dietary fats, especially saturated fats, within the context of carbohydrate restriction.
This groundbreaking investigation, presented by Dr. Alexa Barad, a postdoctoral scholar at Stanford University School of Medicine, at the prestigious NUTRITION 2026 conference, delves into the intricate interplay between an individual’s genetic makeup and their response to low-carbohydrate eating patterns. The study posits that certain genetic profiles may render individuals more susceptible to the LDL-raising effects of saturated fat when carbohydrate consumption is curtailed, thereby explaining the heterogeneous outcomes observed in the population. Dr. Barad articulated this nuanced perspective, stating that the findings underscore a fundamental truth in nutrition: dietary responses are not monolithic, and generalizations can be misleading. What one person experiences as a beneficial dietary shift, another might find detrimental, and this variability can, at least in part, be attributed to inherent genetic predispositions.
The scientific community has long acknowledged the inconsistent impact of low-carbohydrate diets on LDL cholesterol. While the potential advantages for weight loss and improved blood sugar regulation have been widely documented and embraced by many, the variable effects on LDL have remained a significant point of discussion and clinical concern. The researchers in this study aimed to move beyond anecdotal evidence and explore whether genetic profiling could serve as a predictive tool, identifying those who might thrive on reduced carbohydrate intake and those who could face an increased risk of adverse lipid changes.
To address this question, the research team leveraged data from the DIETFITS trial, a substantial randomized controlled study that enrolled over 600 adults. Participants in DIETFITS were assigned to either a healthy low-carbohydrate diet or a healthy low-fat diet and followed these eating patterns for a full year. The primary outcome of the original DIETFITS trial indicated no significant difference in weight loss between the two dietary interventions, highlighting the need for further investigation into other physiological responses.
For this specific genetic analysis, a cohort of 431 DIETFITS participants, for whom comprehensive genetic information was available, was meticulously selected. The researchers then embarked on an in-depth examination of the relationships between participants’ genotypes, their intake of saturated fat, the specific diet they followed, and the resulting changes in their LDL cholesterol levels from the study’s inception to the six-month mark. This detailed approach allowed for a granular understanding of how these factors converged to influence lipid metabolism.
The findings were particularly striking within the group adhering to the low-carbohydrate diet. Those individuals who possessed genetic markers associated with a higher inherent tendency for elevated LDL cholesterol were significantly more likely to experience an increase in their LDL levels when following this dietary pattern. This observation strongly suggests that a genetically driven susceptibility to LDL elevation is a key determinant in the variable responses seen with low-carb diets.
Further dissection of the data revealed that this heightened sensitivity to saturated fat appeared to be the primary mechanism driving these genetic influences. Participants with the most pronounced genetic predisposition for higher LDL cholesterol exhibited the most substantial increases in LDL when their saturated fat intake was greater. Crucially, this correlation between saturated fat consumption and LDL elevation was not observed in participants who were following the low-fat diet, underscoring the specific context in which genetics and dietary fat interact.
A notable methodological advancement in this study was the researchers’ decision to move beyond the analysis of single genetic variants, a common approach in many previous studies. Instead, they employed a polygenic risk score, a sophisticated method that aggregates the effects of thousands of genetic variants across the entire genome. This comprehensive scoring system provides a more robust estimation of an individual’s overall genetic propensity towards higher or lower LDL cholesterol levels, offering a more holistic picture of genetic influence.
Dr. Barad envisions that the future clinical application of these polygenic scores could be transformative, enabling healthcare providers to proactively identify individuals who are at a greater risk of experiencing unfavorable cholesterol fluctuations in response to specific dietary interventions, including carbohydrate restriction. This personalized approach could lead to more tailored dietary recommendations and preventative strategies.
Beyond the realm of genetic testing, the study offers a vital practical takeaway for the general public: the importance of individual monitoring of cholesterol levels, rather than adhering to a one-size-fits-all dietary dogma. Dr. Barad emphasized that the wide spectrum of individual responses to dietary changes necessitates a personalized approach. It is imperative for individuals to understand how their own bodies react to specific dietary modifications, as assuming uniform outcomes can be misleading.
While these findings are compelling, the researchers acknowledge that further investigation is required to validate these results and to ascertain their applicability across a broader and more diverse range of populations. Ensuring that these genetic insights hold true for various ethnic backgrounds and health statuses will be crucial for their widespread clinical utility.
Current established dietary guidelines generally advocate for limiting saturated fat intake to below 10% of daily caloric intake and prioritizing unsaturated fats. For individuals opting for a low-carbohydrate diet, Dr. Barad suggests a strategic emphasis on sources of healthy fats such as nuts, seeds, olive oil, and avocados. Conversely, she advises caution with foods particularly rich in saturated fats, including butter, beef tallow, fatty cuts of meat, and processed meat products. Adopting such a nuanced approach to fat selection within a low-carb framework may serve to mitigate the risk of experiencing an adverse cholesterol response.
The research underpinning this article was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases, the National Heart, Lung, and Blood Institute, and the Stanford Clinical and Translational Science Award, all part of the National Institutes of Health. Additional support was provided by an American Heart Association Postdoctoral Fellowship to Dr. Alexa Barad. The content presented reflects the responsibility of the researchers and does not necessarily represent the official viewpoints of the funding bodies. It is important to note that abstracts presented at NUTRITION 2026, while selected by expert committees, have not undergone the rigorous peer-review process typically required for scientific journal publication. Therefore, the findings presented should be considered preliminary until they are formally published in a peer-reviewed scientific journal.
About the Author
